David Whiteley
Hepatitis C in a new therapeutic era: Recontextualising the lived experience
Whiteley, David; Whittaker, Anne; Elliott, Lawrie; Cunningham-Burley, Sarah
Authors
Anne Whittaker
Lawrie Elliott
Sarah Cunningham-Burley
Abstract
Aims and Objectives
To explore the experience of adults living with hepatitis C in a new era of interferon-free treatment.
Background
Hepatitis C is a leading cause of morbidity and mortality worldwide, posing a significant challenge to global public health. Historically, the treatment of hepatitis C was poorly efficacious and highly demanding, however, more effective and tolerable therapies have become available in high-income nations in recent years. This is the first study to explore how these significant developments in the treatment of hepatitis C may have influenced the experience of those living with the virus, and their understanding of the disease.
Design
A qualitative study underpinned by social phenomenological theory.
Methods
Data were generated through semi-structured interviews with a purposive sample of 20 hepatitis C positive adults living in a large city in Scotland.
Results
Thematic analysis identified three over-riding themes. ‘Positioning hepatitis C’ illustrated how the disease was understood within wider sociocultural, medical and politico-economic contexts. ‘Beyond a physical burden’ emphasised the emotional aspect of infection, and ‘a new uncertainty’ revealed participants’ cautious response to the advances in hepatitis C therapy.
Conclusions
Inter-thematic discourse portrayed the new era of hepatitis C treatment as holding little sway over constructions of the illness, as narratives resonated with previous studies. Such unmoving ‘lay’ understandings of hepatitis C may pose potential barriers to the new therapeutic era from reaching its full potential.
Relevance to clinical practice
How people living with the virus perceive and understand hepatitis C can have an adverse impact on their engagement with care and treatment. Whilst global medical discourse eulogises the arrival of a new era of therapy, there remain significant challenges for nurses engaging those with hepatitis C in therapeutic pathways.
Citation
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2017). Hepatitis C in a new therapeutic era: Recontextualising the lived experience. Journal of Clinical Nursing, https://doi.org/10.1111/jocn.14083
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 19, 2017 |
Online Publication Date | Sep 27, 2017 |
Publication Date | Oct 23, 2017 |
Deposit Date | Sep 29, 2017 |
Publicly Available Date | Sep 28, 2018 |
Journal | Journal of Clinical Nursing |
Print ISSN | 0962-1067 |
Electronic ISSN | 1365-2702 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1111/jocn.14083 |
Keywords | Direct-acting antivirals; hepatitis C; interferon-free treatment, lived experience, social phenomenology, thematic analysis, treatment rationing |
Public URL | http://researchrepository.napier.ac.uk/Output/991847 |
Contract Date | Sep 29, 2017 |
Files
Hepatitis C in a new therapeutic era: Recontextualising the lived experience
(68 Kb)
Document
Copyright Statement
This is the peer reviewed version of the following article: Whiteley, D., Whittaker, A., Elliott, L. and Cunningham-Burley, S. (), Hepatitis C in a new therapeutic era: Recontextualising the lived experience. J Clin Nurs. Accepted Author Manuscript. doi:10.1111/jocn.14083 which has been published in final form at http://dx.doi.org/10.1111/jocn.14083. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving